231 related articles for article (PubMed ID: 16601009)
1. Sperm integrity pre- and post-chemotherapy in men with testicular germ cell cancer.
Spermon JR; Ramos L; Wetzels AM; Sweep CG; Braat DD; Kiemeney LA; Witjes JA
Hum Reprod; 2006 Jul; 21(7):1781-6. PubMed ID: 16601009
[TBL] [Abstract][Full Text] [Related]
2. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer.
Petersen PM; Skakkebaek NE; Vistisen K; Rørth M; Giwercman A
J Clin Oncol; 1999 Mar; 17(3):941-7. PubMed ID: 10071288
[TBL] [Abstract][Full Text] [Related]
3. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.
Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T
J Androl; 2009; 30(3):280-6. PubMed ID: 19136393
[TBL] [Abstract][Full Text] [Related]
4. Impact of chemotherapy and radiotherapy for testicular germ cell tumors on spermatogenesis and sperm DNA: a multicenter prospective study from the CECOS network.
Bujan L; Walschaerts M; Moinard N; Hennebicq S; Saias J; Brugnon F; Auger J; Berthaut I; Szerman E; Daudin M; Rives N
Fertil Steril; 2013 Sep; 100(3):673-80. PubMed ID: 23755953
[TBL] [Abstract][Full Text] [Related]
5. Characterization of sperm chromatin quality in testicular cancer and Hodgkin's lymphoma patients prior to chemotherapy.
O'Flaherty C; Vaisheva F; Hales BF; Chan P; Robaire B
Hum Reprod; 2008 May; 23(5):1044-52. PubMed ID: 18346994
[TBL] [Abstract][Full Text] [Related]
6. Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance.
Hansen SW; Berthelsen JG; von der Maase H
J Clin Oncol; 1990 Oct; 8(10):1695-8. PubMed ID: 1698935
[TBL] [Abstract][Full Text] [Related]
7. Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer.
Brennemann W; Stoffel-Wagner B; Helmers A; Mezger J; Jäger N; Klingmüller D
J Urol; 1997 Sep; 158(3 Pt 1):844-50. PubMed ID: 9258096
[TBL] [Abstract][Full Text] [Related]
8. Relationship of testicular volume to semen profiles and serum hormone concentrations in infertile Japanese males.
Arai T; Kitahara S; Horiuchi S; Sumi S; Yoshida K
Int J Fertil Womens Med; 1998; 43(1):40-7. PubMed ID: 9532468
[TBL] [Abstract][Full Text] [Related]
9. Sperm counts and serum follicle-stimulating hormone levels before and after radiotherapy and chemotherapy in men with testicular germ cell cancer.
Berthelsen JG
Fertil Steril; 1984 Feb; 41(2):281-6. PubMed ID: 6199233
[TBL] [Abstract][Full Text] [Related]
10. Gonadal function after multimodality treatment in men with testicular germ cell cancer.
Palmieri G; Lotrecchiano G; Ricci G; Spiezia R; Lombardi G; Bianco AR; Torino G
Eur J Endocrinol; 1996 Apr; 134(4):431-6. PubMed ID: 8640293
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment follicle-stimulating hormone: a prognostic serum marker of spermatogenesis status in patients treated for germ cell cancer.
Brennemann W; Stoffel-Wagner B; Wichers M; Helmers A; Albers P; Mezger J; Klingmüller D
J Urol; 1998 Jun; 159(6):1942-6. PubMed ID: 9598493
[TBL] [Abstract][Full Text] [Related]
12. Sperm DNA integrity in testicular cancer patients.
Ståhl O; Eberhard J; Jepson K; Spano M; Cwikiel M; Cavallin-Ståhl E; Giwercman A
Hum Reprod; 2006 Dec; 21(12):3199-205. PubMed ID: 16931803
[TBL] [Abstract][Full Text] [Related]
13. Testicular function in patients with testicular cancer treated with bleomycin-etoposide-carboplatin (BEC(90)) combination chemotherapy.
Pectasides D; Pectasides M; Farmakis D; Nikolaou M; Koumpou M; Kostopoulou V; Mylonakis N
Eur Urol; 2004 Feb; 45(2):187-93. PubMed ID: 14734005
[TBL] [Abstract][Full Text] [Related]
14. Effects of the chemotherapy cocktail used to treat testicular cancer on sperm chromatin integrity.
Delbes G; Hales BF; Robaire B
J Androl; 2007; 28(2):241-9; discussion 250-1. PubMed ID: 17021337
[TBL] [Abstract][Full Text] [Related]
15. Reproductive toxicity with and without LHRHA administration during adjuvant chemotherapy in patients with germ cell tumors.
Kreuser ED; Hetzel WD; Hautmann R; Pfeiffer EF
Horm Metab Res; 1990 Sep; 22(9):494-8. PubMed ID: 1701752
[TBL] [Abstract][Full Text] [Related]
16. Fertility after chemotherapy for testicular cancer.
Drasga RE; Einhorn LH; Williams SD; Patel DN; Stevens EE
J Clin Oncol; 1983 Mar; 1(3):179-83. PubMed ID: 6199473
[TBL] [Abstract][Full Text] [Related]
17. Gonadal function in men with testis cancer.
Berthelsen JG; Skakkebaek NE
Fertil Steril; 1983 Jan; 39(1):68-75. PubMed ID: 6293886
[TBL] [Abstract][Full Text] [Related]
18. Impaired testicular function in patients with carcinoma-in-situ of the testis.
Petersen PM; Giwercman A; Hansen SW; Berthelsen JG; Daugaard G; Rørth M; Skakkebaek NE
J Clin Oncol; 1999 Jan; 17(1):173-9. PubMed ID: 10458231
[TBL] [Abstract][Full Text] [Related]
19. Spermatozoal DNA damage in patients with B thalassaemia syndromes.
De Sanctis V; Perera D; Katz M; Fortini M; Gamberini MR
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():185-9. PubMed ID: 19337176
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
Matsumoto AM
J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
